I agree that this site is using cookies. You can find further informations here.
X
Allanore Y
221  results:
english X
Search for persons X
?
1

PRS3 Joint Modelling of Forced Vital Capacity Decline and T..:

Stock, C. ; Kreuter, M. ; Del Galdo, F....
Value in Health.  24 (2021)  - p. S213 , 2021
Link: https://doi.org/10.1016/..
 
?
2

ACE inhibitors in SSc patients display a risk factor for sc..:

on behalf of EUSTAR collaborators ; Bütikofer, Lukas ; Varisco, Pierre A....
Arthritis Research & Therapy.  22 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
3

PMS52 Quality of Life in Ssc-ILD Patients: Understanding th..:

Allanore, Y. ; Constans, J. ; Godard, D....
Value in Health.  23 (2020)  - p. S601 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Serum metabolites as biomarkers in systemic sclerosis-assoc..:

Meier, C. ; Freiburghaus, K. ; Bovet, C....
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
5

Six-week antibiotic therapy after one-stage replacement art..:

Chieffo, G. ; Corsia, S. ; Rougereau, G....
Médecine et Maladies Infectieuses.  50 (2020)  7 - p. 567-574 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Survival and prognosis factors in systemic sclerosis: data ..:

Pokeerbux, M. R. ; Giovannelli, J. ; Dauchet, L....
Arthritis Research & Therapy.  21 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
7

Classification, categorization and essential items for digi..:

EUSTAR co-workers ; Blagojevic, J. ; Bellando-Randone, S....
Arthritis Research & Therapy.  21 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
8

Use of vasoactive/vasodilating drugs for systemic sclerosis..:

EUSTAR co-workers ; Blagojevic, Jelena ; Abignano, G....
Clinical Rheumatology.  39 (2019)  1 - p. 27-36 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Predictors of hypogammaglobulinemia during rituximab mainte..:

Boleto, G. ; Avouac, J. ; Wipff, J....
Seminars in Arthritis and Rheumatism.  48 (2018)  2 - p. 149-154 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Survival and prognosis factors in systemic sclerosis: Data ..:

Pokeerbux, M.R. ; Giovannelli, J. ; Dauchet, L....
La Revue de Médecine Interne.  38 (2017)  - p. A63 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Association betweenRANK, RANKLandOPGpolymorphisms with ACPA..:

Ruyssen-Witrand, Adeline ; Degboé, Yannick ; Cantagrel, A...
RMD Open.  2 (2016)  2 - p. e000226 , 2016
Link: https://doi.org/10.1136/..
 
?
12

Twenty-two points to consider for clinical trials in system..:

Khanna, D. ; Furst, D. E. ; Allanore, Y....
Rheumatology.  54 (2014)  1 - p. 144-151 , 2014
Link: https://doi.org/10.1093/..
 
?
13

MDCT imaging of calcinosis in systemic sclerosis:

Freire, V. ; Becce, F. ; Feydy, A....
Clinical Radiology.  68 (2013)  3 - p. 302-309 , 2013
Link: https://doi.org/10.1016/..
 
?
14

Nailfold capillary abnormalities in erectile dysfunction of..:

Keck, A. D. ; Foocharoen, C. ; Rosato, E....
Rheumatology.  53 (2013)  4 - p. 639-643 , 2013
Link: https://doi.org/10.1093/..
 
?
15

S.4.1 N-terminal pro-brain natriuretic peptide levels predi..:

Thakkar, V. ; Stevens, W. ; Prior, D....
Rheumatology.  51 (2012)  suppl 2 - p. ii8-ii10 , 2012
Link: https://doi.org/10.1093/..
 
1-15